09 Apr 2026
// FDA
06 Feb 2026
// PR NEWSWIRE
30 Jun 2025
// FDA
Latest Content by PharmaCompass
Reset all filters
01 1ARFORMOTEROL TARTRATE
02 3DEFERASIROX
03 1DEFLAZACORT
04 1FOSFOMYCIN TROMETHAMINE
05 3LACOSAMIDE
06 1OXCARBAZEPINE
07 2SAPROPTERIN DIHYDROCHLORIDE
08 1VIGABATRIN
Reset all filters
01 3CAPSULE, EXTENDED RELEASE;ORAL
02 2FOR SOLUTION;ORAL
03 3GRANULE;ORAL
04 2POWDER;ORAL
05 1SOLUTION;INHALATION
06 2SUSPENSION;ORAL
Reset all filters
01 1100MG
02 1100MG/PACKET
03 1150MG
04 1180MG
05 1200MG
06 122.75MG/ML
07 1300MG/5ML
08 1360MG
09 2500MG/PACKET
10 190MG
11 1EQ 0.015MG BASE/2ML
12 1EQ 3GM BASE/PACKET
Reset all filters
01 13RX
RLD : No
TE Code : AN
Dosage Form : SOLUTION; INHALATION
Proprietary Name : ARFORMOTEROL TARTRATE
Dosage Strength : EQ 0.015MG BASE/2ML
Approval Date : 2025-02-03
Application Number : 218380
RX/OTC/DISCN : RX
RLD : No
TE Code : AN
RLD : No
TE Code : AB
Dosage Form : GRANULE; ORAL
Proprietary Name : DEFERASIROX
Dosage Strength : 90MG
Approval Date : 2021-03-09
Application Number : 214559
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : GRANULE; ORAL
Proprietary Name : DEFERASIROX
Dosage Strength : 180MG
Approval Date : 2021-03-09
Application Number : 214559
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : GRANULE; ORAL
Proprietary Name : DEFERASIROX
Dosage Strength : 360MG
Approval Date : 2021-03-09
Application Number : 214559
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : SUSPENSION; ORAL
Proprietary Name : PYQUVI
Dosage Strength : 22.75MG/ML
Approval Date : 2025-06-30
Application Number : 219417
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AA
Dosage Form : FOR SOLUTION; ORAL
Proprietary Name : FOSFOMYCIN TROMETHAMINE
Dosage Strength : EQ 3GM BASE/PACKET
Approval Date : 2026-04-09
Application Number : 217772
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : MOTPOLY XR
Dosage Strength : 100MG
Approval Date : 2023-05-04
Application Number : 216185
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : MOTPOLY XR
Dosage Strength : 150MG
Approval Date : 2023-05-04
Application Number : 216185
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : MOTPOLY XR
Dosage Strength : 200MG
Approval Date : 2023-05-04
Application Number : 216185
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code : AB
Dosage Form : SUSPENSION; ORAL
Proprietary Name : OXCARBAZEPINE
Dosage Strength : 300MG/5ML
Approval Date : 2022-11-30
Application Number : 215332
RX/OTC/DISCN : RX
RLD : No
TE Code : AB